Minireview

Epigenetics of obesity and diabetes in humans

Howard Slomko, Hye J. Heo, Francine H. Einstein

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Understanding the determinants of human health and disease is overwhelmingly complex, particularly for common, late-onset, chronic disorders, such as obesity and diabetes. Elucidating the genetic and environmental factors that influence susceptibility to disruptions in energy homeostasis and metabolic regulation remain a challenge, and progress will entail the integration of multiple assessments of temporally dynamic environmental exposures in the context of each individual's genotype. To meet this challenge, researchers are increasingly exploring the epigenome, which is the malleable interface of gene-environment interactions. Epigenetic variation, whether innate or induced, contributes to variation in gene expression, the range of potential individual responses to internal and external cues, and risk for metabolic disease. Ultimately, advancement in our understanding of chronic disease susceptibility in humans will depend on refinement of exposure assessment tools and systems biology approaches to interpretation. In this review, we present recent progress in epigenetics of human obesity and diabetes, existing challenges, and the potential for new approaches to unravel the complex biology of metabolic dysregulation.

Original languageEnglish (US)
Pages (from-to)1025-1030
Number of pages6
JournalEndocrinology
Volume153
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Epigenomics
Obesity
Gene-Environment Interaction
Systems Biology
Disease Susceptibility
Metabolic Diseases
Environmental Exposure
Cues
Homeostasis
Chronic Disease
Genotype
Research Personnel
Gene Expression
Health

ASJC Scopus subject areas

  • Endocrinology

Cite this

Slomko, H., Heo, H. J., & Einstein, F. H. (2012). Minireview: Epigenetics of obesity and diabetes in humans. Endocrinology, 153(3), 1025-1030. https://doi.org/10.1210/en.2011-1759

Minireview : Epigenetics of obesity and diabetes in humans. / Slomko, Howard; Heo, Hye J.; Einstein, Francine H.

In: Endocrinology, Vol. 153, No. 3, 03.2012, p. 1025-1030.

Research output: Contribution to journalArticle

Slomko, H, Heo, HJ & Einstein, FH 2012, 'Minireview: Epigenetics of obesity and diabetes in humans', Endocrinology, vol. 153, no. 3, pp. 1025-1030. https://doi.org/10.1210/en.2011-1759
Slomko, Howard ; Heo, Hye J. ; Einstein, Francine H. / Minireview : Epigenetics of obesity and diabetes in humans. In: Endocrinology. 2012 ; Vol. 153, No. 3. pp. 1025-1030.
@article{eee431071728477eb6e8b36b001518d0,
title = "Minireview: Epigenetics of obesity and diabetes in humans",
abstract = "Understanding the determinants of human health and disease is overwhelmingly complex, particularly for common, late-onset, chronic disorders, such as obesity and diabetes. Elucidating the genetic and environmental factors that influence susceptibility to disruptions in energy homeostasis and metabolic regulation remain a challenge, and progress will entail the integration of multiple assessments of temporally dynamic environmental exposures in the context of each individual's genotype. To meet this challenge, researchers are increasingly exploring the epigenome, which is the malleable interface of gene-environment interactions. Epigenetic variation, whether innate or induced, contributes to variation in gene expression, the range of potential individual responses to internal and external cues, and risk for metabolic disease. Ultimately, advancement in our understanding of chronic disease susceptibility in humans will depend on refinement of exposure assessment tools and systems biology approaches to interpretation. In this review, we present recent progress in epigenetics of human obesity and diabetes, existing challenges, and the potential for new approaches to unravel the complex biology of metabolic dysregulation.",
author = "Howard Slomko and Heo, {Hye J.} and Einstein, {Francine H.}",
year = "2012",
month = "3",
doi = "10.1210/en.2011-1759",
language = "English (US)",
volume = "153",
pages = "1025--1030",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Minireview

T2 - Epigenetics of obesity and diabetes in humans

AU - Slomko, Howard

AU - Heo, Hye J.

AU - Einstein, Francine H.

PY - 2012/3

Y1 - 2012/3

N2 - Understanding the determinants of human health and disease is overwhelmingly complex, particularly for common, late-onset, chronic disorders, such as obesity and diabetes. Elucidating the genetic and environmental factors that influence susceptibility to disruptions in energy homeostasis and metabolic regulation remain a challenge, and progress will entail the integration of multiple assessments of temporally dynamic environmental exposures in the context of each individual's genotype. To meet this challenge, researchers are increasingly exploring the epigenome, which is the malleable interface of gene-environment interactions. Epigenetic variation, whether innate or induced, contributes to variation in gene expression, the range of potential individual responses to internal and external cues, and risk for metabolic disease. Ultimately, advancement in our understanding of chronic disease susceptibility in humans will depend on refinement of exposure assessment tools and systems biology approaches to interpretation. In this review, we present recent progress in epigenetics of human obesity and diabetes, existing challenges, and the potential for new approaches to unravel the complex biology of metabolic dysregulation.

AB - Understanding the determinants of human health and disease is overwhelmingly complex, particularly for common, late-onset, chronic disorders, such as obesity and diabetes. Elucidating the genetic and environmental factors that influence susceptibility to disruptions in energy homeostasis and metabolic regulation remain a challenge, and progress will entail the integration of multiple assessments of temporally dynamic environmental exposures in the context of each individual's genotype. To meet this challenge, researchers are increasingly exploring the epigenome, which is the malleable interface of gene-environment interactions. Epigenetic variation, whether innate or induced, contributes to variation in gene expression, the range of potential individual responses to internal and external cues, and risk for metabolic disease. Ultimately, advancement in our understanding of chronic disease susceptibility in humans will depend on refinement of exposure assessment tools and systems biology approaches to interpretation. In this review, we present recent progress in epigenetics of human obesity and diabetes, existing challenges, and the potential for new approaches to unravel the complex biology of metabolic dysregulation.

UR - http://www.scopus.com/inward/record.url?scp=84857437426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857437426&partnerID=8YFLogxK

U2 - 10.1210/en.2011-1759

DO - 10.1210/en.2011-1759

M3 - Article

VL - 153

SP - 1025

EP - 1030

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 3

ER -